Skip to main content
. 2017 Jun 28;38(2):819–828. doi: 10.3892/or.2017.5766

Figure 3.

Figure 3.

(A) In vivo tumor growth inhibition in BALB/c mice treated with various doses of quercetin (50, 100 and 200 mg/kg;intraperitoneally) inducted CT26 and (B) MCF-7 cell line. There were significant differences after 18 days of treatment between the quercetin-treated groups and the control group (dextrose 5%). P<0.001.